1. Home
  2. ALCYU vs MRK Comparison

ALCYU vs MRK Comparison

Compare ALCYU & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALCYU
  • MRK
  • Stock Information
  • Founded
  • ALCYU N/A
  • MRK 2000
  • Country
  • ALCYU
  • MRK United States
  • Employees
  • ALCYU 3
  • MRK N/A
  • Industry
  • ALCYU
  • MRK Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALCYU
  • MRK Health Care
  • Exchange
  • ALCYU NYSE
  • MRK Nasdaq
  • Market Cap
  • ALCYU N/A
  • MRK 198.5B
  • IPO Year
  • ALCYU N/A
  • MRK N/A
  • Fundamental
  • Price
  • ALCYU N/A
  • MRK $81.00
  • Analyst Decision
  • ALCYU
  • MRK Buy
  • Analyst Count
  • ALCYU 0
  • MRK 15
  • Target Price
  • ALCYU N/A
  • MRK $113.71
  • AVG Volume (30 Days)
  • ALCYU N/A
  • MRK 18.0M
  • Earning Date
  • ALCYU N/A
  • MRK 07-29-2025
  • Dividend Yield
  • ALCYU N/A
  • MRK 4.00%
  • EPS Growth
  • ALCYU N/A
  • MRK 667.14
  • EPS
  • ALCYU N/A
  • MRK 6.88
  • Revenue
  • ALCYU N/A
  • MRK $63,922,000,000.00
  • Revenue This Year
  • ALCYU N/A
  • MRK $2.42
  • Revenue Next Year
  • ALCYU N/A
  • MRK $5.77
  • P/E Ratio
  • ALCYU N/A
  • MRK $11.77
  • Revenue Growth
  • ALCYU N/A
  • MRK 4.10
  • 52 Week Low
  • ALCYU N/A
  • MRK $73.31
  • 52 Week High
  • ALCYU N/A
  • MRK $129.93
  • Technical
  • Relative Strength Index (RSI)
  • ALCYU 43.55
  • MRK 54.36
  • Support Level
  • ALCYU $11.36
  • MRK $78.14
  • Resistance Level
  • ALCYU $12.00
  • MRK $83.07
  • Average True Range (ATR)
  • ALCYU 0.00
  • MRK 1.84
  • MACD
  • ALCYU 0.00
  • MRK 0.21
  • Stochastic Oscillator
  • ALCYU 0.00
  • MRK 64.15

About ALCYU ALCHEMY INVTS ACQUISITION CORP 1 UNIT 1 CL A COM & 1/2 WT

Alchemy Investments Acquisition Corp 1 is a blank check company.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Share on Social Networks: